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Abstract
Q fever is caused by the obligate intracellular bacterium Coxiella burnetii. In vitro growth of
the bacterium is usually limited to viable eukaryotic host cells imposing experimental con-
straints for molecular studies, such as the identification and characterisation of major viru-
lence factors. Studies of pathogenicity may benefit from the recent development of an
extracellular growth medium for C. burnetii. However, it is crucial to investigate the consis-
tency of the virulence phenotype of strains propagated by the two fundamentally different
culturing systems. In the present study, we assessed the viability of C. burnetii and the lipo-
polysaccaride (LPS) encoding region of the bacteria in both culture systems as indirect but
key parameters to the infection potential of C. burnetii. Propidium monoazide (PMA) treat-
ment-based real-time PCR was used for enumeration of viable C. burnetii which were vali-
dated by fluorescent infectious focus forming unit counting assays. Furthermore, RNA
isolated from C. burnetiipropagated in both the culture systems was examined for LPS-
related gene expression. All thus far known LPS-related genes were found to be expressed
in early passages in both culturing systems indicating the presence of predominantly the
phase I form of C. burnetii. Finally, we used immune-competent mice to provide direct evi-
dence, that the relative virulence of different C. burnetii strains is essentially the same for
both axenic and cell-based methods of propagation.
Introduction
Coxiella burnetii, the etiological agent of Q fever, is an obligate intracellular bacterium that
multiplies within a modified phagolysosome of eukaryotic cells. Q fever is primarily a zoonotic
infection that is transmitted via inhalation of contaminated aerosols associated with domestic
livestock operations [1]. In humans Q fever manifests as acute and chronic infections. Acute
infection symptoms commonly include fever, pneumonia or hepatitis [2, 3] whereas persistent
infections lead to chronic disease commonly presenting as endocarditis, which is difficult to
treat with antibiotics [4]. A large outbreak occurred in the Netherlands during the years 2007–
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2010 where more than 40,000 people were assumed to be infected [5–7]. The causes for the
outbreak are not fully understood and one of the main reasons speculated were the hyper viru-
lent behaviour of the circulating strains which might have resulted in the increased zoonotic
potential [6, 8, 9]. Unfortunately, more accessible cell-free cultivation [10, 11] of C. burnetii to
be used in, for instance genetic modification or sample multiplication studies were not linked
to virulence measurements yet. Validation of such tools assists in improved understanding of
the pathogenesis of C. burnetii, which in turn may contribute to a more efficient control of
the disease.
The obligate intracellular nature of C. burnetii imposes several obstacles and makes it to be
largely experimentally intractable to use molecular-genetic approaches aiming at a better under-
standing of its pathogenesis and virulence factors. Studying these factors of C. burnetiimay bene-
fit from the recent development of an extracellular growth medium [10, 11]. However, it is
crucial to know whether the viability of C. burnetii strains, as well as aspects of phase variation
and virulence characteristics is not affected by the two different culturing systems. So far proce-
dures to determine the viability of the bacteria based on direct enumeration methods (for in-
stance colony counting) are not easily achievable for C. burnetii, although this is needed to
accurately determine inoculation doses in animal experiments. Less often the viability of bacteria
is measured by counting the infectious plaques/colonies in cells infected with serially diluted sam-
ples, but this method is tedious, less sensitive and limited to cell-based culture systems [12].
Therefore, quantification of bacteria is usually done by total DNA qPCRmethods on selected sin-
gle-copy genes [13–15]. Nevertheless, qPCRmethod fail to differentiate between live and dead
cells showing the necessity to develop easier methods to quantify live amounts of C. burnetii.
The production of a structurally and antigenetically unique lipopolysaccharide (LPS) mole-
cule is an important feature in C. burnetii as LPS is one of the important virulence factors of
the organism. The presence or absence of LPS also largely correlates with the phase-variation
phenomenon in C. burnetii [16]. From the two phases, phase I is characterised by the presence
of full LPS and is typically the virulent variant whereas phase II has a truncated LPS and usually
considered avirulent [17]. All the LPS coding genes are located in a 38 kb region in the C. bur-
netii genome and it has been observed that chromosomal deletions in this region result in anti-
genic phase variation from phase I to phase II [18, 19]. The shift from phase I to phase II
occurs usually due to repeated passages of the strains in cultures or embryonated eggs [17, 20],
but the molecular mechanisms influencing the LPS modifications still remain unclear.
Propagation of C. burnetii in cell-based cultures is considered the gold standard for in vitro
growth. The development of an axenic (cell-free) growth medium for C. burnetii has greatly fa-
cilitated genetic manipulation and the isolation of single colonies on solid medium, which is
not possible with cell-based cultivation methods [10, 11, 21–24]. However, the cell-free system
is an enhanced artificial environment for C. burnetii cultivation in comparison to cell-based
propagation, which closely mimics in vivo infection conditions. Although C. burnetii grown in
cell-free medium exhibited developmental forms characteristic of in vivo grown organisms and
are infective [11], it is not known whether they have altered virulence characteristics compared
to C. burnetii grown in cell-based culture.
Within the scope of virulence factor characterisation, the aim of the present study was to in-
vestigate, whether propagation in two different in vitro culturing systems affects the viability,
phase variation and relative virulence of C. burnetii strains. To assess viability of the C. burnetii
strains, we used propidium monoazide (PMA) dye after comparing it with ethidium monoa-
zide (EMA) dye for selective PCR amplification of DNA from viable bacterial cells [25] as well
as with fluorescent infectious focus forming units counting (FFU) [12, 26, 27] and counting
colony forming units (CFU) [10]. To determine the phase of the strains, expression of LPS cod-
ing genes was studied by using microarrays on RNA isolated from low and high passaged C.
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burnetii strains. The level of gene expression served as an indicator to predict the functional
state of the genes present in the LPS coding region. The gene expression studies were further
validated by using raw next generation sequencing reads to assess for any potential deletions of
genes involved in LPS synthesis. Ultimately, the relative virulent phenotype of C. burnetii
strains was determined by experimental infection using an immune-competent mice model
[28–31]. This study provides evidence that cell-free propagation of C. burnetii does not affect
its viability, phase variation and relative virulence as seen by mouse virulence bioassay.
Materials and Methods
Animals
Two independent animal experiments were conducted using Specific-Pathogen-Free Swiss fe-
male OF1 mice (Charles River, l’Arbresle, France). For Experiment 1 (E1) and Experiment 2
(E2), 6 and 7 week old mice were used respectively. The mice were housed under sterile condi-
tions in biosafety level 3 facilities and acclimatized for one week before experimental infection.
Each group was housed separately and consisted of 10 mice.
Ethics statement
Animal experiments were approved by the animal experiment commission of the Central Vet-
erinary Institute of Wageningen UR, and conducted in accordance with the Dutch regulations
on animal experimentation (Registration numbers: 2010011.b, 2012126.a). Humane end points
were defined prior to the experiments and all possible measures were taken to minimise
animal suffering.
C. burnetii strains and cultures
In this study the isolates X09003262–001 (3262); X08014160–001 (601) and X08014160–002
(602) were used. These isolates were primarily isolated from the placentas of goats that aborted
during the Q fever outbreak in the Netherlands (2007–2010) [5]. These 3 isolates were molecu-
lar typed as 2 genetically different strains (602 and 3262 similar molecular MLVA genotype) [5]
and were initially propagated in Buffalo Green Monkey (BGM) cells (European Collection of
Cell Cultures, Salisbury, U.K) without antibiotics as described previously [30]. Two additional
strains included in the study were Nine-Mile RSA 493 (NM) and Scurry Q217 (scurry) provided
by D. Frangoulidis (Bundeswehr Institute of Microbiology, Munich) and were initially propa-
gated in the same way. The stock cultures of all the strains propagated in BGM cells were stored
at -80°C. Prior to experimentally infecting mice, the strains were propagated for a few passages
(n<4x times) in cell based and cell free culture systems in order to adapt the strains to the new
(cell free) culture system [10] and to synchronise the passage numbers of the strains.
Viability PCR and quantification of C. burnetii
To determine viability of C. burnetii, PMA and EMA dyes were compared on strains cultured
from cell-based and cell-free culture system. The protocol is essentially described before [25],
where EMA was used to a final concentration of 100 μM to assess the viability of C. burnetii. A
similar final concentration of 100 μM of EMA and PMA (Geniul, Spain) was used in this study.
Briefly, the dyes were added to the samples in opaque tubes and incubated in dark for 30 min
at 4°C and vortexed regularly. The samples were transferred to high transparent tubes and
were photo-activated for 30 minutes using PhAST blue system (Genuil, Spain). DNA was iso-
lated from the samples by using NucliSENS easyMag machine (BioMérieux, USA) as per man-
ufacture instructions. One tenth of the DNA was used as a template for detection and
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quantification of number of C. burnetii by using a TaqMan-based real-time PCR targeting the
single copy gene (CBU_0407a, gene bank number AY502846) encoding a C. burnetii specific
hypothetical protein as previously published [30]. A standard curve was generated by using
ADIAVET COX Positive control (Adiagene, Marcy l’Étoile, France) according to the manufac-
turer’s instructions.
Fluorescent infectious focus forming unit’s measurements
Viability PCRs were validated by a direct enumeration method using microscopic counting of
fluorescent infectious focus forming units (FFU). The viable number of bacterial cells were es-
tablished by inoculating serial dilutions of bacterial cells (10–1 to 10–9) from both culture sys-
tems on confluent monolayers of BGM cells in 24 well tissue culture plates (Costar, Corning,
USA) containing 15 mm coverslips (Menzel GmbH, Germany). After 24 hours incubation at
37°C in 5% CO2, infected cells were washed twice and incubated for 6 days. Infected cells were
demonstrated by indirect immunofluorescence assay using C. burnetii specific monoclonal an-
tibody (MAB313-oregon green, Squarix). Number of viable bacteria in the inoculum was deter-
mined from the last dilution which resulted in at least one infected cell [12]. To further
confirm the FFU counts, CFU counts were also performed with the same bacterial dilutions
used for FFU on solid agar plates as mentioned previously [10].
RNA preparation and microarray analysis
Total RNA was isolated from C. burnetii strains by using Direct-zol RNAMiniprep Kit (Zymo
Research, Irvine, USA) as per manufacturer’s instructions. Poly-A tails were tagged to bacterial
total RNA (500 ng) by using Poly-A Polymerase Tailing kit (Epicenter Illumina company,
Madison, USA). This RNA was used as starting material for Agilent’s protocols for amplifica-
tion, labelling, hybridization, washing and scanning of the C. burnetiimicroarrays. The C. bur-
netii custom microarray consisted of user-designed probes (https://earray.chem.agilent.
com/earray) covering the complete LPS-gene repertoire of several C. burnetii strains (NCBI,
Accession numbers: AE016828.2, CP000733.1, CP001020.1, CP001019.1, CP001021.1) and
were synthesized by Agilent Technologies (Santa Clara, CA, USA). Data was obtained through
Agilent's feature extraction software (Version 10.7.3.1) and analysed by using GeneSpring soft-
ware (Agilent Technologies).
Genome coverage analysis
Total DNA from high passage C. burnetii strains (n>30x times) propagated in cell-free culture
was isolated by phenol-chloroform method [32] after overnight incubation with ATL lysis
buffer and proteinase K (QIAGEN, Hilden, Germany). Whole genome sequencing was per-
formed using 250 bp paired-end sequencing libraries (Nextera TAG-mentation sequencing
kits, Epicentre, Madison, USA) on an Illumina MiSeq sequencer. High quality paired end reads
were mapped against the reference NM RSA493 genome available from the NCBI database
(Accession number: AE016828.2) using Bowtie2 alignment tool [33]. The average coverage
and standard deviation (excluding repetitive regions) were obtained for the whole genome
using a sliding-window approach and were used to calculate the coverage of genes involved in
LPS synthesis (CBU0676 to CBU0706). A coverage below the minus 2 SD interval was consid-
ered as a significantly deleted gene. Apart from genome analysis, the protein profiles of low
and high passaged 602 strain were also analysed by SDS-PAGE using the whole cell lysates, as
described previously [34]. The method was basically the same except for staining of proteins
with SYPRO Orange dye (Molecular probes) and visualising the protein profiles with a Ty-
phoon Trio imager and ImageQuant 5.2 software (Molecular Dynamics).
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Infection mice and collection of tissues
Two independent infection experiments were performed where 10 Swiss OF1 mice per strain
were inoculated intraperitoneally with 0.2 ml suspension of C. burnetii in phosphate buffer sa-
line (PBS) in order that each mouse receives a dose of 105 genome copy equivalents as deter-
mined by quantitative PCR. PBS was used for the negative controls. The inocula used to infect
mice were tested for number of viable cells after the infection experiments by using PMA-PCR.
The samples were freeze thawed once and similar percentages (55–65%) of alive bacterial cells
were found in the inocula. All the strains from both culture systems were found to be in phase I
as measured by expression profiles of LPS encoding genes using a microarray. One week after
inoculation the mice were euthanized, weighed and their spleen were aseptically removed,
weighed and frozen at -80°C. Weights were used for determining relative spleen weights
(means of spleen weight/body weight (%)).
Measurements of bacterial loads from spleens of mice
To quantify the number of C. burnetii in mice spleens, DNA was extracted from the spleen by
using the DNeasy Blood and Tissue Kit (QIAGEN, Hilden, Germany). Briefly, the spleen was
homogenised after addition of PBS. About 200 μl suspension was taken and added to tissue
lysis buffer (buffer ATL) and proteinase K. DNA was extracted from this suspension according
to the protocol for gram-negative bacteria as recommended by the manufacturer.
The DNA was used as a template for detection and quantification of number of C. burnetii
by using a TaqMan-based real-time PCR as explained above. The bacterial genome copy num-
ber from PCR was log transformed and determined as the mean log2 values per gram spleen.
Statistical analysis
Samples and sample-derived data from each mouse were kept separate for all treatments and
analysis. Data from viability of PMA treated samples, normalised expression of LPS genes
and relative virulence from groups of mice are expressed as means ± standard deviation and
compared by independent two tailed student t-tests. Differences were considered significant
at a p value of <0.01.
Results
Evaluation and comparison of PMA and EMA dyes for the C. burnetii
live/dead assay
Propidium monoazide (PMA) and Ethidium monoazide (EMA) were utilized to selectively
allow real-time PCR amplification of target DNA from viable C. burnetii cells. The basic princi-
ple involves selective penetration of these dyes only into dead bacterial cells with compromised
membrane integrity but not into the live cells with intact membranes. Once inside the cells, the
dyes cross link with DNA upon exposure to bright light and inhibits its amplification by PCR
[35]. In the present study serially diluted C. burnetii (NM strain) containing approximately 106
cells/ml from cell-based and cell-free culture matrix were treated with EMA and PMA. The re-
sults show a clear difference between the two dyes. In PMA treated samples 50–60% of alive
cells were detected, whereas in EMA treated samples only few cells (1–2%) were detected to
be viable based on the DNA amplification compared to untreated samples (Fig. 1A). We con-
cluded that, PMA dye selectively entered dead cells that allowed efficient amplification of live
C. burnetii, whereas EMA inhibits DNA amplification of almost all cells. To validate the effi-
ciency of PMA-PCR, limiting dilution FFU assays were conducted to measure the number of
viable cells based on the last dilution that resulted in at least one infected cell. Similar amounts
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of viable bacteria from both the culture systems were measured as seen by PMA-PCR (Fig. 1A).
Furthermore, CFU counts [10] also confirmed the FFU counts, where the last dilution resulting
in colonies corresponded with the same dilution which resulted in at least one infected cell in
FFU assay (data not shown). To test the potential in discriminating live and dead cells by these
Fig 1. Viability PCR ofC. burnetii on the single copy gene in cell-based and cell-free matrix. A) Comparison of PMA and EMA PCR with limited dilution
FFU assays. PMA and EMAmeasurements were performed on normal and heat-inactivated (dead) cells of C. burnetii. FFU assays were performed to
validate PMA-PCRmeasurements. B) C. burnetii strains were exposed with PMA and the genomic DNA yield was expressed as a percentage of alive cells
corresponding to non-PMA-treated sample. The error bars represent standard deviations from two independent replicates. NS indicates p-value> 0.01.
doi:10.1371/journal.pone.0121661.g001
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dyes, the samples were subjected to heat treatment at 99°C for 30 min. Very high signal reduc-
tion was seen in samples both treated with EMA and PMA with>99% decrease in DNA ampli-
fication. To further test the reproducibility of this technique, different strains from cell-based
and cell-free culture (3262, Scurry and NM) were tested with PMA followed by qPCR. In PMA
treated samples 30–65% of alive cells were detected based on the DNA amplification (Fig. 1B)
with respect to non-PMA treated samples. No significant differences were seen between culture
systems with respect to viability of cells (Fig. 1B).
Gene expression in LPS coding genes of C. burnetii
Within the 38 kb region of C. burnetii strains the junctions of large, nested deletions are located
which can lead to phase variation [18]. We first tried to find evidence for the presence or ab-
sence of these deletions using a PCR approach (data not shown) targeting on multiple locations
in this region. By this approach, we did not find any clear evidence for the presence of deletions
as would be seen in a phase II variant [18]. To obtain additional evidence for the absence of
LPS gene deletions, we subsequently used a microarray approach to measure the expression
level of genes in this region in cells grown in both cell-based and cell-free culture systems
(Fig. 2A). The average gene expression was normalised with expression of the housekeeping
gene rpoB [36] of C. burnetii and was plotted for the 602 strain as a representative example.
Here, a measurable expression indicates the presence of transcribed RNA from genes located
in the 38 kb region, while no expression points towards a possible loss of function due to regu-
lation or deletion events. The comparison of normalised LPS gene expressions from strain 602
shows similar expression levels for all genes in the LPS encoding region in both cell-based and
cell-free cultured strains. This supports the earlier conclusion that for both culturing systems
no deletion in the LPS region could be detected. A similar trend of LPS expression is seen in
other strains (data not shown) that were used in the virulence bioassay of mice as described in
this study, indicating that the majority of cells as cultured by low passage-number in the cell-
based and cell-free system are in phase I. In contrast, high passaged 602 strain from cell-free
culture showed a very low expression of LPS genes at the beginning of the LPS encoding region
(CBU0676 to CBU0697) and high expression of the genes towards the end (CBU0698 to
CBU0706) (Fig. 2A). Comparing the regulation of LPS encoding genes of high passaged cell-
free culture with low passaged cell-based and cell-free culture strains showed a significant
(p<0.01) down regulation of CBU0676 to CBU0697 genes with a minimum fold change< 4
(data not shown). These significant difference between the higher passaged cells (n>30x times)
and the lower passaged cells (n<10x times) shows loss of function of the genes (CBU0676 to
CBU0697) at the beginning of the LPS cluster and a consecutive variation from phase I to
phase II in a significant proportion of the cell population.
Deletion of genes involved in LPS formation by whole genome sequence
analysis
The low expression of genes involved in LPS synthesis in the high passaged C. burnetii strain
were further analysed for any deletions by whole genome sequencing. The coverage of reads
for LPS encoding genes (CBU0676 to CBU0697) were significantly lower than the genes pres-
ent at the end (CBU0698 to CBU0706) of the LPS encoding region (Fig. 2B) indicating dele-
tions of these genes in a significant proportion of the cell population and a phase variation
moving into a phase II form. The data also demonstrated that the occurrence of (growing) dele-
tions is most likely an on-going event during passage since the read-mapping indicates a mixed
metagenomic population at this LPS encoding region of the genome.
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Mouse bioassay
All mice remained clinically healthy during the course of the experiment. However, at autopsy
mice inoculated with C. burnetii strains showed significant splenomegaly as compared to con-
trol mice. The mice bioassay’s showed a statistically significant level of splenomegaly in
Fig 2. Normalised LPS gene expression profiles and genome coverage ofC. burnetii 602 strain as a representative example. A) Here average
transcript signal per gene was normalised with the average transcript signal of housekeeping gene rpoB of C. burnetii. The normalised gene expressions are
plotted for 602 low passage strain in cell-based and cell-free culture systems and 602 high passaged cell-free culture strain. The dashed lines represent
standard deviations from two independent replicates. B) Genomic coverage of genes involved in LPS synthesis of a high passaged cell-free culture 602
strain. A coverage below the minus 2 SD interval (dashed line) was considered as a significantly deleted gene. The x-axis for both the A and B graphs are
shown as a scaled mini-map of C. burnetii LPS encoding genes. Each data point represents to its corresponding gene (CBU0676 to CBU0706) labelled as 1
to 31 genes in the gene map. The genes indicated in grey are hypothesized to be involved O-antigen synthesis and export. Genes indicated in black are
hypothesized to be involved in other LPS synthesis steps and carbohydrate metabolism.
doi:10.1371/journal.pone.0121661.g002
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infected animals compared to the respective controls (p<0.01), except for the cell-based grown
Scurry strain (E1) group (p = 0.10).
Relative virulence of C. burnetii strains in mice
The relative virulence of C. burnetii strains was expressed as the “relative spleen weight per
number of C. burnetii bacteria” which considers both the degree of splenomegaly and the num-
ber of C. burnetii present in the spleen of infected mice. The in vivo growth of bacteria in the
mice spleens were measured by qPCR assay, where the bacterial DNA was quantified by
CBU_0407a single copy gene (results not shown). As shown in Fig. 3 and Table 1, the relative
virulence of a particular strain is not significantly affected by the in vitro system that is used to
propagate the bacteria (p>0.01). These results indicate that the phenotypic expressions of viru-
lence of the used C. burnetii strains in mice is independent of the in vitro culture system chosen
for propagating the strains. No statistically significant differences for the relative virulence
(p>0.01) were obtained between cell-based cultured strains of 3262 and 601 in these two
Fig 3. Changes in relative virulence.Relative virulence of different strains cultured in cell-based and cell-free systems expressed as the relative spleen
weight per number ofC. burnetii. E1, experiment 1; E2, experiment 2.
doi:10.1371/journal.pone.0121661.g003
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independent experiments (E1 and E2), clearly highlighting the reproducibility for this measure
in the mouse virulence bioassay.
Discussion
In the present study we used three different methods to evaluate virulence-associated charac-
teristics of different C. burnetii strains cultured in cell-based and cell-free systems. We did not
observe any difference in the number of viable cells in the two culturing systems as determined
by the use of PMA-PCR. Furthermore, we did not find any evidence for the occurrence of loss
of function of genes in the LPS encoding region in the low passaged strains from both the cul-
turing systems. Since the loss of gene function of the genes in the LPS cluster can be associated
with the variation of the virulent phase I to the avirulent phase II, we do not expect significant
differences in the phase I to phase II ratios in the low passages of C. burnetii strains in both the
culturing systems. Finally, we provide evidence that the relative virulence of C. burnetii strains
is not affected by the cell-based or cell-free method of propagation as measured in an immune-
competent mouse model. Therefore, our results clearly demonstrate that the cell-free culture
system does not significantly influence the relative virulent phenotype of the tested strains.
This indicates that the cell-free culturing system is invaluable for the identification and charac-
terisation of virulence factors of C. burnetii while allowing the investigation of molecular mech-
anisms involved in the pathogenesis of this obligate intracellular bacterium.
Our study reports the use of PMA-PCR, which worked better in our hands compared with
EMA-PCR for quantification of viable cells of C. burnetii. The efficient quantification of geno-
mic DNA from live cells by PMA or EMA treatment followed by PCR has been reported previ-
ously in different bacterial species [25, 35, 37–39]. It is one of the few current methods
available for C. burnetii [25], which can be used to determine and quantify viable cells.
Table 1. A signiﬁcant difference matrix of C. burnetii strains from cell or cell-free culture evaluated for relative virulence in a mouse bioassay.
Strain Source Country Culture Scurry NM 602 601 3262
cella cfb cell cf cell cf cell E1c cell E2d cf cell E1 cell E2
Scurry human USA cell n.a
cf - n.a
NM tick USA cell - - n.a
cf - - - n.a
602 goat NL cell * * - - n.a
cf * * - - - n.a
601 goat NL cell E1 - - * - * * n.a
cell E2 - - - - * * - n.a
cf - - * * * * - - n.a
3262 goat NL cell E1 - - - - * * - - - n.a
cell E2 - - * - * * - - - - n.a
Signiﬁcant differences in relative virulence between different strains (where p<0.01, * and p>0.01,-).
- non-signiﬁcant differences between cell and cell-free cultures.
n.a, Indicate non applicable insigniﬁcant self-comparisons.
a Cell, Cell-culture;
b cf, Cell-free culture;
c E1, experiment 1;
d E2, experiment 2.
doi:10.1371/journal.pone.0121661.t001
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Compared to PMA-PCR, decrease in PCR amplification was seen in EMA-PCR resulting in
very low numbers of viable cells. In previous studies, EMA treatment showed loss of more than
60% genomic DNA due to penetration in live cells, whereas PMA was found to selectively pen-
etrate only dead cells [35, 37, 39, 40]. This higher impermeability of PMA through the intact
cells might be due to the higher charge of PMA as suggested previously [35]. In samples treated
at high temperatures, a high decrease in PCR amplification efficiency was seen compared to
untreated cells, consistent with previously observations in other bacterial species. Therefore, a
complete inhibition of PCR amplification of DNA from dead cells could not be expected at the
tested concentrations of C. burnetii cells [39, 41, 42]. One of the important parameters to con-
sider in this method is the matrix of the culture system the bacteria were propagated in, as
non-specific host DNA also contributes in the efficiency of this technique. EMA-PCR seemed
to work well in egg homogenate matrix of C. burnetii which contains very high amounts of
host DNA as previously described [25], but not on cell-based culture matrix which contain rel-
atively less host DNA or no host DNA as in cell-free culture matrix. Hence, PMA-PCR was
seen to mitigate the drawbacks observed with EMA-PCR in cell-based and cell-free culture sys-
tems. Also the viability counts obtained by PMA-PCR corresponded closely with direct enu-
meration FFU assay and CFU assay (data not shown) showing it as an efficient method to
enumerate viable C. burnetii.
Transcriptomics studies of all LPS encoding genes located in a 38 kb region in the C. burne-
tii genome is one of the robust and easy ways to detect loss of function of all these genes, which
basically results in phase variation. The measured gene expression profiles showed all the low
passaged strains of C. burnetii to be in phase I. Several other molecular techniques can also be
used to determine the C. burnetii phase variation including approaches such as determining
LPS sugar composition and quantification [43–46], PCR’s on all genes of LPS coding regions
[19], microarray-based genome comparisons [47], reverse transcriptase-PCR for expression of
genes [19] and genome sequencing [18, 19]. These methods are rather elaborative and tedious.
Our result of transcriptomic measurements of a representative low passaged strain shows simi-
lar levels of expression of all genes in the LPS encoding region, without any significant differ-
ences in both cell-based and cell-free culture system. However, the high passaged cell-free
cultured strain, showed significant (p<0.01) lower expression of several genes (CBU0676 to
CBU0697) in major part of this region, compared with the low passaged cell-based and cell-
free culture systems. Further, significant (p<0.01) down regulation of these genes with a fold
change of< 4 confirms the possible loss of gene function, which can result in a transition from
phase I to phase II phenotype of the bacterium. This significant decrease of transcripts could
also be regulatory and/or a physical deletion event within the LPS genes. Although lower, the
expression of these genes are still detected suggesting the presence of mixtures of phase I and II
variants of the strain, where the observed remaining transcripts of these genes are most likely
from bacteria still in phase I form. High expression of genes were seen in this strain towards
the end of the region (CBU0698 to CBU0706) suggesting the possible remains of these regions
in the phase II variants.
Whole genome sequencing was performed to investigate whether any deletion events result
in the observed low expression/regulation of genes involved in LPS synthesis. Here we used the
depth of coverage in whole genome sequence data. A significant decrease in coverage was ob-
served in the genes which showed low expression (CBU0676 to CBU0697) indicative for a dele-
tion. Some of the deleted genes are involved in O-antigen biosynthesis or other LPS
biosynthetic steps (Fig. 2) and its deletion may result in severe impairment of LPS synthesis
correlating with phase variation [18, 48]. Such large deletions were also seen previously in
other phase II strains such as 9Mi/Baca (deletion from CBU0678 to CBU0694), 9Mi/II/C1 and
9Mi/II/C4 (deletion from CBU0678 to CBU0698) [18, 19]. The coverage of the genes
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(CBU0698 to CBU0706) present at the end of the LPS encoding region were higher, corre-
sponding to the observed normal expression of these genes. Hence, the lower and higher read
depths of genes obtained from sequencing (Fig. 2B) corresponded to lower and higher expres-
sion of the same genes obtained from expression studies (Fig. 2A). Similar results were also
seen from SDS-PAGE analysis, where whole cell lysates of low and high passaged 602 strain
had a similar profile of protein fragments which reflected those of the phase 1 type (bands be-
tween 21–14 kDa). In addition, the high passaged strain comparatively had a more prominent
band at 10.7 kDa which is characteristic of phase II type. Hence, both phase I and phase II char-
acteristic profiles were observed in high passaged cell-free cultured strains (Fig. 4) [34]. We
conclude that low passaged strains from both the culture systems were in a predominant phase
I form, and high passaged cell-free cultured strain shows possible deletions resulting in loss of
gene function in the beginning of this LPS encoding region which is progressing throughout
the region resulting in a phase II variant of the strain. Hence, cell surface LPS of C. burnetii is
not significantly changed in the cell-free culture system similar to cell-based culture system in
its early passages. Eventually phase variation occur due to multiple passages in cell-free culture
system, due to loss of LPS side chain as suggested previously [49].
In this present study we used immune-competent Swiss OF1 mice to evaluate the virulence
properties of different C. burnetii strains. This model is currently used by several groups for
evaluating pathogenicity of C. burnetii with consistent outcomes [28]. We assessed the viru-
lence of C. burnetii strains using “splenomegaly” (increase in weight of spleen in relation to the
body weight) and “RT-PCR quantification of bacteria in the spleen” as the most important
read-out parameters [13, 15, 50]. Splenomegaly in response to infection was observed in these
mice without any adverse clinical signs or mortality at 7 days post infection. Even at 21 days
after infection no mortality of mice was observed and the splenomegaly reduced as well as the
Fig 4. SDS-PAGE ofC. burnetiiwhole cell lysates of low passaged cell-based and cell-free cultures and high passaged cell-free cultured 602
strain. Three serial dilutions (1:5) marked as 1, 2 and 3 for all samples were used. The red box indicates the phase II specific bands seen in high passaged
cell-free cultured strain.
doi:10.1371/journal.pone.0121661.g004
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number of bacteria in the spleens, most likely indicating a level of clearance of the infection
(data not shown). Also the degree of splenomegaly correlated with the bacterial load in the
spleen as explained before [51]. All strains were capable of inducing pathological changes in
the Swiss OF1 mice, showing its sensitivity to Q fever agent.
The strains propagated in cell-based and cell-free culture systems did not show any signifi-
cant differences in their relative virulence, showing relative virulence is independent of the cul-
ture system in which the strains are propagated in. We combined both, splenomegaly and
bacterial load, which are most likely related, as virulence parameters to determine relative viru-
lence of C. burnetii. The extent of splenomegaly and presence of C. burnetii in the spleen was
strain dependent indicating that the strains most likely differentially affect the influx of (T)
cells into the spleen and thereby facilitate bacterial clearance [15]. The colonization of spleen
was a good indicator of infectivity, highlighting the relevance of these measurements for com-
paring strain virulence. Hence, the relative virulence showed strain-specific (p<0.01) but simi-
lar virulence values (p>0.01) for the same strain, irrespective the method of in vitro
propagation for the tested low passage strains (Table 1). It is also expected that strains propa-
gated from both the culture systems would equally loose virulence with respect to higher pas-
sages due to loss of LPS structure as seen previously [49]. Finally, the two individual
experiments conducted showed reproducible relative virulence in 3262 and 601 cell-based cul-
tured strains, underlining the precision of virulence associated measurements in the present
mouse virulence bioassay.
In conclusion, our results provide evidence that the axenic culture system does not signifi-
cantly influence the viability, phase variation and relative virulence of C. burnetii strains com-
pared with cell-based culture. Thereby the cell-free propagation is an invaluable tool when
studying molecular mechanisms underlying differences in virulence by using molecular genetic
studies, which are not feasible using cell-based cultivation. Ultimately this system could be use-
ful for development of effective subunit vaccines or production of recombinant antigens, which
would offer great potential in the control of Q fever outbreaks as well as limiting its transmis-
sion to humans.
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